Follow
Paul Spearman
Title
Cited by
Cited by
Year
Neonatal infectious diseases: evaluation of neonatal sepsis
A Camacho-Gonzalez, PW Spearman, BJ Stoll
Pediatric Clinics 60 (2), 367-389, 2013
7562013
Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions
YL Lu, P Spearman, L Ratner
Journal of virology 67 (11), 6542-6550, 1993
4071993
Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly
P Spearman, JJ Wang, N Vander Heyden, LEE Ratner
Journal of virology 68 (5), 3232-3242, 1994
3511994
AP-3 directs the intracellular trafficking of HIV-1 Gag and plays a key role in particle assembly
X Dong, H Li, A Derdowski, L Ding, A Burnett, X Chen, TR Peters, ...
Cell 120 (5), 663-674, 2005
3062005
Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism
P Spearman, R Horton, L Ratner, I Kuli-Zade
Journal of virology 71 (9), 6582-6592, 1997
2721997
Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production
V Varthakavi, RM Smith, SP Bour, K Strebel, P Spearman
Proceedings of the National Academy of Sciences 100 (25), 15154-15159, 2003
2492003
Induction of broadly cross-reactive antibody responses to the influenza HA stem region following H5N1 vaccination in humans
AH Ellebedy, F Krammer, GM Li, MS Miller, C Chiu, J Wrammert, ...
Proceedings of the National Academy of Sciences 111 (36), 13133-13138, 2014
2322014
HIV‐1 egress is gated through late endosomal membranes
S Nydegger, M Foti, A Derdowski, P Spearman, M Thali
Traffic 4 (12), 902-910, 2003
2272003
Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane
J Hammonds, JJ Wang, H Yi, P Spearman
PLoS pathogens 6 (2), e1000749, 2010
1872010
The I Domain Is Required for Efficient Plasma Membrane Binding of Human Immunodeficiency Virus Type 1 Pr55Gag
S Sandefur, V Varthakavi, P Spearman
Journal of virology 72 (4), 2723-2732, 1998
1781998
Mapping and Characterization of the N-Terminal I Domain of Human Immunodeficiency Virus Type 1 Pr55Gag
S Sandefur, RM Smith, V Varthakavi, P Spearman
Journal of virology 74 (16), 7238-7249, 2000
1692000
QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans
TG Evans, MJ McElrath, T Matthews, D Montefiori, K Weinhold, M Wolff, ...
Vaccine 19 (15-16), 2080-2091, 2001
1662001
Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial
MJ Mulligan, DI Bernstein, P Winokur, R Rupp, E Anderson, N Rouphael, ...
Jama 312 (14), 1409-1419, 2014
1422014
APOBEC3G multimers are recruited to the plasma membrane for packaging into human immunodeficiency virus type 1 virus-like particles in an RNA-dependent process requiring the NC …
A Burnett, P Spearman
Journal of virology 81 (10), 5000-5013, 2007
1382007
A Novel Fluorescence Resonance Energy Transfer Assay Demonstrates that the Human Immunodeficiency Virus Type 1 Pr55Gag I Domain Mediates Gag-Gag …
A Derdowski, L Ding, P Spearman
Journal of virology 78 (3), 1230-1242, 2004
1282004
Correlated fluorescence microscopy and cryo-electron tomography of virus-infected or transfected mammalian cells
CM Hampton, JD Strauss, Z Ke, RS Dillard, JE Hammonds, E Alonas, ...
Nature protocols 12 (1), 150-167, 2017
1212017
The pericentriolar recycling endosome plays a key role in Vpu‐mediated enhancement of HIV‐1 particle release
V Varthakavi, RM Smith, KL Martin, A Derdowski, LA Lapierre, ...
Traffic 7 (3), 298-307, 2006
1212006
Independent segregation of human immunodeficiency virus type 1 Gag protein complexes and lipid rafts
L Ding, A Derdowski, JJ Wang, P Spearman
Journal of virology 77 (3), 1916-1926, 2003
1212003
Myristoylation is required for human immunodeficiency virus type 1 Gag-Gag multimerization in mammalian cells
H Li, J Dou, L Ding, P Spearman
Journal of virology 81 (23), 12899-12910, 2007
1192007
A RhoA-derived peptide inhibits syncytium formation induced by respiratory syncytial virus and parainfluenza virus type 3
MK Pastey, TL Gower, PW Spearman, JE Crowe, BS Graham
Nature medicine 6 (1), 35-40, 2000
1182000
The system can't perform the operation now. Try again later.
Articles 1–20